Features of conservative therapy of benign prostatic hyperplasia in patients with metabolic syndrome: " Treat to Target "
Purpose of the study. To improve the results of treatment of benign prostatic hyperplasia with symptoms of the lower urinary tract in the presence of concomitant metabolic syndrome.Materials and methods. The investigation included 103 patients aged 42 to 75 years with a reliable diagnosis of BPH and...
Saved in:
| Main Authors: | V. B. Filimonov, P. V. Vasin, V. N. Panchenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2020-12-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/635 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
by: Ansh Bhatia, et al.
Published: (2024-12-01) -
WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024-11-01) -
IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01) -
Genetic Predisposition to Benign Prostatic Hyperplasia: Where Do We Stand?
by: Martin Hennenberg, et al.
Published: (2024-12-01) -
Analysis of risk factors for bladder neck contracture after transurethral endoscopic surgery for benign prostatic hyperplasia
by: Yingbing Wu, et al.
Published: (2024-12-01)